Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Reversible aggregation of PABPN1 pre-inclusion structures.

Raz V, Abraham T, van Zwet EW, Dirks RW, Tanke HJ, van der Maarel SM.

Nucleus. 2011 May-Jun;2(3):208-18. doi: 10.4161/nucl.2.3.15736.

2.

Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein.

Raz V, Routledge S, Venema A, Buijze H, van der Wal E, Anvar S, Straasheijm KR, Klooster R, Antoniou M, van der Maarel SM.

Am J Pathol. 2011 Oct;179(4):1988-2000. doi: 10.1016/j.ajpath.2011.06.044. Epub 2011 Aug 18.

3.

Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.

Messaed C, Dion PA, Abu-Baker A, Rochefort D, Laganiere J, Brais B, Rouleau GA.

Neurobiol Dis. 2007 Jun;26(3):546-57. Epub 2007 Feb 15.

PMID:
17418585
4.

In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1.

Tavanez JP, Calado P, Braga J, Lafarga M, Carmo-Fonseca M.

RNA. 2005 May;11(5):752-62. Epub 2005 Apr 5.

5.

HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy.

Fan X, Messaed C, Dion P, Laganiere J, Brais B, Karpati G, Rouleau GA.

Can J Neurol Sci. 2003 Aug;30(3):244-51.

PMID:
12945950
6.
7.

PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions.

Corbeil-Girard LP, Klein AF, Sasseville AM, Lavoie H, Dicaire MJ, Saint-Denis A, Pagé M, Duranceau A, Codère F, Bouchard JP, Karpati G, Rouleau GA, Massie B, Langelier Y, Brais B.

Neurobiol Dis. 2005 Apr;18(3):551-67.

PMID:
15755682
8.

Structural basis for a PABPN1 aggregation-preventing antibody fragment in OPMD.

Impagliazzo A, Tepper AW, Verrips TC, Ubbink M, van der Maarel SM.

FEBS Lett. 2010 Apr 16;584(8):1558-64. doi: 10.1016/j.febslet.2010.03.010. Epub 2010 Mar 10.

9.

Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.

Verheesen P, de Kluijver A, van Koningsbruggen S, de Brij M, de Haard HJ, van Ommen GJ, van der Maarel SM, Verrips CT.

Hum Mol Genet. 2006 Jan 1;15(1):105-11. Epub 2005 Nov 30.

PMID:
16319127
10.

Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy.

Bengoechea R, Tapia O, Casafont I, Berciano J, Lafarga M, Berciano MT.

Neurobiol Dis. 2012 Apr;46(1):118-29. doi: 10.1016/j.nbd.2011.12.052. Epub 2012 Jan 10.

PMID:
22249111
11.

Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions.

Villagra NT, Bengoechea R, Vaqué JP, Llorca J, Berciano MT, Lafarga M.

Mol Cell Neurosci. 2008 Mar;37(3):622-33. doi: 10.1016/j.mcn.2007.12.012. Epub 2007 Dec 15.

PMID:
18255312
12.

Polyalanine-independent conformational conversion of nuclear poly(A)-binding protein 1 (PABPN1).

Winter R, Kühn U, Hause G, Schwarz E.

J Biol Chem. 2012 Jun 29;287(27):22662-71. doi: 10.1074/jbc.M112.362327. Epub 2012 May 8.

13.
14.

Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy.

Raz V, Sterrenburg E, Routledge S, Venema A, van der Sluijs BM, Trollet C, Dickson G, van Engelen BG, van der Maarel SM, Antoniou MN.

BMC Neurol. 2013 Jul 1;13:70. doi: 10.1186/1471-2377-13-70.

15.

PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression.

Klein AF, Ebihara M, Alexander C, Dicaire MJ, Sasseville AM, Langelier Y, Rouleau GA, Brais B.

Exp Cell Res. 2008 May 1;314(8):1652-66. doi: 10.1016/j.yexcr.2008.02.005. Epub 2008 Feb 23.

PMID:
18367172
16.

Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death.

Fan X, Dion P, Laganiere J, Brais B, Rouleau GA.

Hum Mol Genet. 2001 Oct 1;10(21):2341-51.

PMID:
11689481
17.

Animal model of oculopharyngeal muscular dystrophy.

Uyama E, Hino H, Araki K, Takeya M, Uchino M, Yamamura K.

Acta Myol. 2005 Oct;24(2):84-8.

PMID:
16550922
18.
19.

The dynamism of PABPN1 nuclear inclusions during the cell cycle.

Marie-Josée Sasseville A, Caron AW, Bourget L, Klein AF, Dicaire MJ, Rouleau GA, Massie B, Langelier Y, Brais B.

Neurobiol Dis. 2006 Sep;23(3):621-9. Epub 2006 Jul 24.

PMID:
16860991
20.

Oculopharyngeal muscle dystrophy: fine structure and mRNA expression levels of PABPN1.

Schröder JM, Klossok T, Weis J.

Clin Neuropathol. 2011 May-Jun;30(3):94-103.

PMID:
21545772

Supplemental Content

Support Center